RESUMEN
ECMO is a modified heart-lung bypass system for treatment of moribund neonates. The techniques are described. Our experience with 19 patients reveals a survival rate of 79 percent. In the future, with advances in technology, ECMO may become less invisible and extended to a larger population of newborns.
Asunto(s)
Oxigenación por Membrana Extracorpórea/métodos , Oxigenación por Membrana Extracorpórea/instrumentación , Oxigenación por Membrana Extracorpórea/mortalidad , Predicción , Humanos , Recién Nacido , Tasa de SupervivenciaRESUMEN
In order to study the usefulness of upper mid-arm circumference (MAC) and mid-arm circumference:head circumference ratio (MAC:HC) measurements in assessing longitudinal growth in hospitalized preterm infants, we prospectively measured weights, lengths, occipitofrontal head circumferences (OFC), MACs, MAC:HCs, weight/length for age, nutritional intakes, and serum transthyretin and albumin levels in 50 preterm, low-birth-weight, appropriate for gestational age newborn infants during their first 4 postnatal weeks and at hospital discharge. At some time during hospitalization, weight measurements were abnormal (greater than or equal to 2SD from the gestational age mean) in 48% of the infants as compared with 24% with abnormal MAC measurements (p = 0.002). Abnormal MAC:HCs occurred in 25% of the infants as compared with 68% with abnormal weight/length for age values (p less than 0.001). During weeks 2-4, when nutritional intakes were adequate and serum transthyretin and albumin levels were normal, mean weight gain velocity was less than intrauterine rates and was significantly slower than MAC velocities, which were at or greater than intrauterine rates (p less than 0.001). At discharge, when all infants were gaining weight at intrauterine rates, weight measurements were still abnormal in 28% of the infants as compared with 10% of infants who had abnormal MACs (p = 0.005). Similarly, only 12% of infants had abnormal MAC:HCs as compared with 25% of infants with abnormal weight/length for age values at discharge (p = 0.05). The MAC and MAC:HC are useful for assessing longitudinal growth in preterm infants since they do not overestimate the prevalence of malnourishment during periods of apparent protein-calorie sufficiency.
Asunto(s)
Antropometría/métodos , Recien Nacido Prematuro/crecimiento & desarrollo , Brazo/anatomía & histología , Cefalometría , Insuficiencia de Crecimiento/diagnóstico , Hospitalización , Humanos , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido de Bajo Peso/crecimiento & desarrollo , Recién Nacido , Estudios Prospectivos , Aumento de PesoRESUMEN
We measured arm muscle and fat areas in 22 preterm appropriate for gestational age infants at birth (mean +/- 1 SD birth weight: 1,640 +/- 484 g; gestational age: 31 +/- 2 weeks). Birth arm muscle and fat areas correlated significantly with gestational age (arm muscle: r = 0.86; p less than 0.001; arm fat: r = 0.75; p less than 0.001) and with birth weight. Deviations of birth weights from gestational age means (birth weight z-scores) were related more to variations in arm muscle area (r = 0.69; p less than 0.001) rather than arm fat area (r = 0.44; p = 0.04). Sixteen infants were followed over 4 weeks. They were most physiologically unstable (mean Physiologic Stability Index score = 5.3 +/- 3.5) during the first postnatal week when they also all lost weight. Their mean arm muscle area decreased significantly during the first week by greater than 10%, whereas the mean arm fat area remained unchanged. First week arm muscle losses were directly correlated with the lack of protein intake (r = 0.52; p less than 0.05). The regression equation predicted a protein intake of 4.06 g/kg/day (95% confidence interval: 2.3-6.4) to prevent first week muscle loss. Enteral intake and weight gain were established after week 1, accompanied by a significant reduction in physiologic instability (PSI score = 1.9 +/- 1.9; p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Tejido Adiposo/crecimiento & desarrollo , Brazo/crecimiento & desarrollo , Recien Nacido Prematuro/crecimiento & desarrollo , Desarrollo de Músculos , Humanos , Lactante , Recién NacidoRESUMEN
We assessed the relationship between neonatal hypoglycemia and newborn iron status in 15 hypoglycemic, large-for-date newborn infants, 12 of whom were infants of diabetic mothers. These infants had significantly lower mean serum iron concentrations, ferritin concentrations, percent iron-binding saturation and calculated iron stores, and significantly higher mean transferrin concentrations, total iron-binding capacity concentrations and mid-arm circumference:head circumference ratios when compared with either 15 euglycemic large-for-date or 15 euglycemic appropriate-for-date control infants (p less than 0.001 for all comparisons). All hypoglycemic infants had ferritin concentrations below the 5th percentile as compared to 3% of controls (p less than 0.001), and 67% had transferrin concentrations above the 95th percentile (controls: 0%; p less than 0.001). Only the hypoglycemic infants demonstrated a significant negative linear correlation between ferritin and transferrin concentrations (r = -0.83; p less than 0.001). Decreased serum iron concentrations were associated with size at birth (r = -0.60; p = 0.01) and with increased red cell iron (r = -0.60; p = 0.01), implying a redistribution of iron dependent on the degree of fetal hyperglycemia and hyperinsulinemia. Infants with increased red cell iron had more profound neonatal hypoglycemia. These results show a significant association between decreased iron stores and neonatal hypoglycemia in macrosomic newborn infants associated with a significant shift of iron into red blood cells.
Asunto(s)
Eritrocitos/metabolismo , Macrosomía Fetal/sangre , Hipoglucemia/sangre , Hierro/sangre , Humanos , Hiperinsulinismo/congénito , Recién Nacido , Estudios ProspectivosRESUMEN
We prospectively measured serum transferrin levels weekly from birth until discharge in 33 preterm newborn infants hospitalized on the newborn intensive care unit (n = 130 weeks) to study whether transferrin levels accurately reflect recent nutritional intakes and predict subsequent changes in anthropometric measurements and serum protein levels. Mean daily protein and caloric intakes were no greater during weeks when transferrin levels increased than when levels decreased. There were weak but statistically significant linear relationships between protein intake and transferrin levels (r = 0.24, p less than 0.01), caloric intake and transferrin levels (r = 0.27, p less than 0.01), and magnitudes of weekly changes in protein intake and transferrin levels (r = 0.31, p less than 0.001), and magnitudes of weekly changes in caloric intake and transferrin levels (r = 0.27, p less than 0.01). Transferrin levels did not reflect same-week weight or midarm circumference (MAC) gains, nor did they predict the following week's gains. Mean anthropometric measurement gains were similar following weeks when transferrin levels increased or decreased. There were no positive linear relationships between the magnitudes of changes in transferrin levels and same-week weight gain (r = -0.35), same-week MAC gain (r = -0.27), or following-week MAC gain (r = 0.01). Weak correlations were found with following-week albumin levels (r = 0.32, p less than 0.001) and with same-week transthyretin levels (r = 0.44, p less than 0.001). Weekly serum transferrin levels are not useful for longitudinal surveillance of protein-energy status in preterm infants.